SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-070636
Filing Date
2024-06-07
Accepted
2024-06-07 16:12:34
Documents
12
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20240605.htm   iXBRL 8-K 50526
2 EX-10.1 fgen-ex10_1.htm EX-10.1 242470
  Complete submission text file 0000950170-24-070636.txt   441663

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240605.xsd EX-101.SCH 23887
15 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240605_htm.xml XML 4509
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 241029516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)